Empowered Funds’s Atrium Therapeutics RNA Stock Holding History
Bought
Maintained
Sold
Other funds holding RNA
Empowered Funds's RNA Position: Q3 2026 in Review
Empowered Funds opened a new position in Atrium Therapeutics (RNA) in Q3 2026: 19,729 shares worth $163K. The stake represents ﹤0.01% of the portfolio and ranks #2325 among its holdings.
148 funds tracked by Wall St. Rank hold RNA as of Q3 2026.
- Empowered Funds held 19,729 shares of Atrium Therapeutics worth $163K as of Q3 2026.
- Atrium Therapeutics was a new Empowered Funds position in Q3 2026.
- Atrium Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2325 holding.
- 148 funds tracked by Wall St. Rank held Atrium Therapeutics as of Q3 2026.
Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.